Literature DB >> 7814617

Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of beta-adrenergic receptor kinase 1 and 2.

A De Blasi1, G Parruti, M Sallese.   

Abstract

Beta-adrenergic receptor kinase (beta ARK) is a serine-threonine kinase involved in the process of homologous desensitization of G-coupled receptors. beta ARK is a member of a multigene family, consisting of six known subtypes, also named G protein-coupled receptor kinases (GRK 1-6). In this study we investigated the expression of GRKs during the process of T cell activation, which is of fundamental importance in regulating immune responses. T cell activation was induced by exposing mononuclear leukocytes (MNL) to PHA and confirmed by tritiated thymidine incorporation measurement. A substantial increase of GRK activity (as measured by in vitro phosphorylation of rhodopsin) was found after 48 h (331 +/- 80% of controls) and 72 h (347 +/- 86% of controls) of exposure to PHA. A threefold increase of beta ARK1 immunoreactivity was found in MNL exposed to PHA for 72 h. Persistent activation of protein kinase C (PKC) by 10 nM 12-O-tetradecanoylphorbol-13-acetate (TPA) was able to increase beta ARK activity to the same extent as PHA, suggesting a PKC-mediated mechanism. The kinetic of beta-adrenergic-stimulated cAMP production was substantially modified in TPA and PHA-activated cells, indicating that the increased GRK activity resulted in an increased beta-adrenergic homologous desensitization. A three- to fourfold increase in GRK activity was also observed in a population of T cell blasts (> 97% CD3+) exposed to PHA for 48-72 h. A significant increase in beta ARK1 and beta ARK2 mRNA expression was observed 48 h after mitogen stimulation, while mRNA expression of GRK5 and GRK6 was not changed. In conclusion our data show that the expression of GRK subtypes is actively and selectively modulated according to the functional state of T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814617      PMCID: PMC295405          DOI: 10.1172/JCI117641

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Induction of high-affinity paf receptor expression during T cell activation.

Authors:  C Calabresse; M C Nguer; O Pellegrini; J Benveniste; Y Richard; Y Thomas
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

2.  Specific protein kinases modulated during T cell mitogenesis. Activity of a 55-kDa serine kinase is associated with growth arrest in human T cells.

Authors:  G A Evans; D Linnekin; S Grove; W L Farrar
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

Review 3.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.

Authors:  K S Ullman; J P Northrop; C L Verweij; G R Crabtree
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 4.  Structure and mechanism of the G protein-coupled receptor kinases.

Authors:  J Inglese; N J Freedman; W J Koch; R J Lefkowitz
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

5.  beta-Adrenergic responsiveness of human peripheral lymphocytes after mitogenic transformation with phytohemagglutinin.

Authors:  E Paietta; J D Schwarzmeier
Journal:  Biochem Pharmacol       Date:  1983-10-15       Impact factor: 5.858

Review 6.  Protein kinase C and T cell activation.

Authors:  N Berry; Y Nishizuka
Journal:  Eur J Biochem       Date:  1990-04-30

7.  A beta-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the beta 2-adrenergic receptor.

Authors:  G Kong; R Penn; J L Benovic
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

8.  High expression of beta-adrenergic receptor kinase in human peripheral blood leukocytes. Isoproterenol and platelet activating factor can induce kinase translocation.

Authors:  T T Chuang; M Sallese; G Ambrosini; G Parruti; A De Blasi
Journal:  J Biol Chem       Date:  1992-04-05       Impact factor: 5.157

9.  Identification of additional members of human G-protein-coupled receptor kinase multigene family.

Authors:  B Haribabu; R Snyderman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

10.  Two isoforms of G protein-coupled receptor kinase 4 identified by molecular cloning.

Authors:  M Sallese; M S Lombardi; A De Blasi
Journal:  Biochem Biophys Res Commun       Date:  1994-03-15       Impact factor: 3.575

View more
  20 in total

Review 1.  Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity.

Authors:  Richard T Premont
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 2.  Regulatory mechanisms that modulate signalling by G-protein-coupled receptors.

Authors:  S K Böhm; E F Grady; N W Bunnett
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

Review 3.  The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.

Authors:  Priscila Y Sato; J Kurt Chuprun; Mathew Schwartz; Walter J Koch
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

4.  G-protein-coupled receptor kinase activity is increased in hypertension.

Authors:  R Gros; J L Benovic; C M Tan; R D Feldman
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

5.  Glucocorticoids reverse IL-1beta-induced impairment of beta-adrenoceptor-mediated relaxation and up-regulation of G-protein-coupled receptor kinases.

Authors:  Judith C W Mak; Takeshi Hisada; Michael Salmon; Peter J Barnes; K Fan Chung
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

6.  G protein-coupled receptor kinase 2 negatively regulates chemokine signaling at a level downstream from G protein subunits.

Authors:  M Carmen Jiménez-Sainz; Cristina Murga; Annemieke Kavelaars; María Jurado-Pueyo; Beate F Krakstad; Cobi J Heijnen; Federico Mayor; Anna M Aragay
Journal:  Mol Biol Cell       Date:  2005-10-12       Impact factor: 4.138

7.  Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN).

Authors:  Teresa K Tarrant; Rishi R Rampersad; Denise Esserman; Lisa R Rothlein; Peng Liu; Richard T Premont; Robert J Lefkowitz; David M Lee; Dhavalkumar D Patel
Journal:  Clin Immunol       Date:  2008-07-26       Impact factor: 3.969

8.  Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.

Authors:  Karl Balabanian; Angélique Levoye; Lysiane Klemm; Bernard Lagane; Olivier Hermine; Julie Harriague; Françoise Baleux; Fernando Arenzana-Seisdedos; Françoise Bachelerie
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

9.  GRK2 mediates TCR-induced transactivation of CXCR4 and TCR-CXCR4 complex formation that drives PI3Kγ/PREX1 signaling and T cell cytokine secretion.

Authors:  Brittney A Dinkel; Kimberly N Kremer; Meagan R Rollins; Michael J Medlyn; Karen E Hedin
Journal:  J Biol Chem       Date:  2018-07-17       Impact factor: 5.157

10.  Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.

Authors:  Corina Anastasaki; David H Gutmann
Journal:  Hum Mol Genet       Date:  2014-07-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.